MedPath

The PREMOD Trial: A Randomized Controlled Trial of Umbilical Cord Milking vs. Delayed Cord Clamping in Premature Infants

Not Applicable
Completed
Conditions
Intraventricular Hemorrhage
Interventions
Procedure: Delayed Cord Clamping
Procedure: Umbilical Cord Milking
Registration Number
NCT01866982
Lead Sponsor
Sharp HealthCare
Brief Summary

Premature babies can be very sick and have bleeding in the brain. Giving babies more blood before cutting the umbilical cord by delayed cord clamping or umbilical cord milking has been shown to reduce the risk of bleeding in the brain. This may be related to improving perfusion to the brain. However, some studies suggest that delayed cord clamping may not increase hemoglobin or blood volume in babies delivered by cesarean section. Milking the umbilical cord may give more blood in babies delivered by Cesarean Section may improve perfusion and reduce bleeding in the brain.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
197
Inclusion Criteria
  • Singleton or multiples pregnancies in patients admitted for medically indicated delivery or in advanced spontaneous preterm labor with imminent delivery at 23 0/7 - 31 6/7 weeks gestation
Exclusion Criteria
  • Planned vaginal breech delivery
  • Major fetal abnormalities (defined as those that are lethal or require prenatal or postnatal surgery)
  • Fetal death in utero
  • Red cell isoimmunization
  • Patients who are incapable of informed consent (unconscious, severely ill, mentally handicapped), or are unwilling to undergo randomization
  • Placenta accreta or abruption

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Delayed Cord ClampingDelayed Cord ClampingDelayed clamping of the umbilical cord for 45-60 seconds
Umbilical Cord MilkingUmbilical Cord MilkingMilking the umbilical cord 4 times towards the infants at a speed of 20cm/2 seconds
Primary Outcome Measures
NameTimeMethod
Superior Vena Cava Flow<12 hours of life
Secondary Outcome Measures
NameTimeMethod
Use of uterotonic agentsup to 1 hour after birth
Maternal hemoglobinwithin 48 hours after delivery
Severe intraventricular hemorrhage (grade 3 or 4)up to 24 weeks after birth
Phototherapyup to 24 weeks after birth

Requirement and length of phototherapy

Delivery Room Interventions10 minutes of life
Neurodevelopmental impairment 18-36 months18-36 months
Necrotizing enterocolitisup to 24 weeks after birth
Apgar score <7 at 5 minutesat 5 minutes after birth
Number of blood transfusions while in the neonatal intensive care unitup to 24 weeks after birth
Ionotropic supportup to 24 weeks after birth

Requirement and length of ionotropic support

Neonatal intensive care unit (NICU) length of stayup to 24 weeks after birth
Polycythemiaup to 24 hours of life
Peak transcutaneous and/or serum bilirubin concentrationsup to 24 weeks after birt
Blood pressure in first 2 hours of admission to neonatal intensive care unit2 hours after birth
Neonatal deathup to 24 weeks of life
Umbilical cord pH < 7.0up to 30 minutes after birth
Intraventricular Hemorrhage detected on Head Ultrasoundup to 24 weeks after birth
Hemoglobin4 weeks of life
Ventilator timeup to 24 weeks after birth

Trial Locations

Locations (3)

Loma Linda Medical Center

🇺🇸

Loma Linda, California, United States

Sharp Mary Birch

🇺🇸

San Diego, California, United States

University of California, San Diego

🇺🇸

San Diego, California, United States

© Copyright 2025. All Rights Reserved by MedPath